Issue 10/2022
Content (13 Articles)
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis
Denise Bernhardt, Laila König, Anca Grosu, Benedikt Wiestler, Stefan Rieken, Wolfgang Wick, Jens Gempt, Sandro M. Krieg, Friederike Schmidt-Graf, Felix Sahm, Bernhard Meyer, Bernd J. Krause, Cordula Petersen, Rainer Fietkau, Michael Thomas, Frank Giordano, Andrea Wittig-Sauerwein, Jürgen Debus, Ghazaleh Tabatabai, Peter Hau, Joachim Steinbach, Stephanie E. Combs
Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy
Martin Salzmann, Klaus Hess, Kristin Lang, Alexander H. Enk, Berit Jordan, Jessica C. Hassel
Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy
R. Dumke, C. Dumke, F. Eberle, Ch. Nimsky, U. Keber, R. Engenhart-Cabillic, S. Lautenschläger
Evaluation of the ability of the Brainlab Elements Cranial Distortion Correction algorithm to correct clinically relevant MRI distortions for cranial SRT
Paul Retif, Abdourahamane Djibo Sidikou, Christian Mathis, Romain Letellier, Emilie Verrecchia-Ramos, Rémi Dupres, Xavier Michel
Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO)
S. Rogers, B. Baumert, O. Blanck, D. Böhmer, J. Boström, R. Engenhart-Cabillic, E. Ermis, S. Exner, M. Guckenberger, D. Habermehl, H. Hemmatazad, G. Henke, F. Lohaus, S. Lux, S. Mai, D. Minasch, A. Rezazadeh, C. Steffal, S. Temming, A. Wittig, C. Zweifel, O. Riesterer, S. E. Combs
Stereotactic radiotherapy of brain metastases: clinical impact of three-dimensional SPACE imaging for 3T-MRI-based treatment planning
Thomas Welzel, Rami A. El Shafie, Bastian v. Nettelbladt, Denise Bernhardt, Stefan Rieken, Jürgen Debus
Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors
Francesco Cuccia, Rosario Mazzola, Vanessa Figlia, Niccolò Giaj-Levra, Luca Nicosia, Francesco Ricchetti, Michele Rigo, Giorgio Attinà, Claudio Vitale, Edoardo Pastorello, Ruggero Ruggieri, Filippo Alongi
Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study
Cem Onal, Ozan Cem Guler, Pervin Hurmuz, Guler Yavas, Burak Tilki, Ezgi Oymak, Cagdas Yavas, Gokhan Ozyigit
Antiemetic prophylaxis for chemoradiotherapy-induced nausea and vomiting in locally advanced head and neck squamous cell carcinoma: a prospective phase II trial
Zekun Wang, Wenyang Liu, Jianghu Zhang, Xuesong Chen, Jingbo Wang, Kai Wang, Yuan Qu, Xiaodong Huang, Jingwei Luo, Jianping Xiao, Guozhen Xu, Li Gao, Junlin Yi, Ye Zhang
Correction to: Comparison of 3D and 4D Monte Carlo optimization in robotic tracking stereotactic body radiotherapy of lung cancer
Mark K. H. Chan, Rene Werner, Miriam Ayadi, Oliver Blanck
Risikostandardisierte Mortalitätsraten übertreffen als Qualitätsindikator die typischen „Mindestzahlen“ in der onkologischen Chirurgie – ein neuer Blick auf Krankenhauszentralisationen mithilfe nationaler bevölkerungsbezogener Daten
Zsolt Sziklavari, G. G. Grabenbauer
Multimodale Therapieansätze beim Hochrisikoprostatakarzinom – was wann?
Etienne Mathier, Astrid Heusel, Mohamed Shelan
Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie
Alexander Rühle, Nils H. Nicolay